Mytrus, an innovative clinical technology and services company for medical and pharmaceutical research, today announced that the University of Alabama at Birmingham (UAB) will use its iPad® application in an upcoming pilot study supported by the U.S. Department of Health & Human Services Agency for Healthcare Research and Quality. UAB is evaluating how digital tools might simplify enrollment and enhance patient understanding during the informed consent process. Kenneth G. Saag, MD, Msc, professor in the UAB Department of Medicine, will lead the study.
For more specific information on UAB’s usage of the Mytrus iPad application, read UAB’s article, “UAB studying high tech way to secure informed consent in research trials” by Bob Shepard, published earlier this month.
Using animation and other visual imagery, the Mytrus iPad application is the first in the industry to condense the complex and critical disclosure information required at the start of a clinical trial into an easy-to-understand, digitized format. This new approach not only helps patients better understand the clinical trial process; it helps researchers gain valuable insight into the speed and effectiveness of the informed consent process in multi-center studies.
“The Mytrus application gives study sponsors a window into the informed consent process that they’ve never had before,” said Anthony Costello, CEO of Mytrus. “Like many sponsors we work with, the University of Alabama at Birmingham also recognizes that increasing a patient’s understanding and comfort level during consent is the best way to retain highly motivated and protocol compliant patients throughout the study.”
Related Links:
Greenphire and Mytrus Partner to Provide Web-based Solutions for Patient Recruitment and Retention
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.